FRANK KARBE - 07 Jul 2021 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Principal Fin'l & Accounting
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
07 Jul 2021
Net transactions value
-$70,296
Form type
4
Filing time
09 Jul 2021, 16:27:07 UTC
Next filing
26 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale $70,296 -3,232 -1.5% $21.75 212,296 07 Jul 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
F2 The shares were sold at prices ranging from $21.75 to $21.83. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.